PAC-1

N/A

Report date: 2025/05/18 20:00:07
NME

Base Information

Drug NamePAC-1
Drug Alias NameProcaspase activating compound 1PAC-1VO-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 activators
TargetsCaspase-3
Therapy Area/IndicationsUveal melanomaSolid tumoursCarcinoma, Renal Cell +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVanquish Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVanquish Oncology IncHealthpartners Institute
Active IndicationsN/A
Inactive IndicationsUveal melanomaSolid tumoursCarcinoma, Renal Cell +[7] 

Other Information

ATC CodeN/A
Related LinksWikipedia